Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.

Stem cell reviews and reports - 1 Aug 2016

Baghbaderani Behnam Ahmadian, Syama Adhikarla, Sivapatham Renuka, Pei Ying, Mukherjee Odity, Fellner Thomas, Zeng Xianmin, Rao Mahendra S

Abstract excerpt

We have recently described manufacturing of human induced pluripotent stem cells (iPSC) master cell banks (MCB) generated by a clinically compliant process using cord blood as a starting material (Baghbaderani et al. in Stem Cell Reports, 5(4), 647-659, 2015). In this manuscript, we describe the detailed characterization of the two iPSC clones generated using this process, including whole genome sequencing (WGS),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD34
Share to Comparative Genomic Hybridization

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Embryoid Bodies

Share to Fetal Blood

Share to Karyotype

Share to Pluripotent Stem Cells

Share to Stem Cell Transplantation

Share to Tissue Banks

Source

Open in PubMed Open full text

Identifiers

PMID: 27283945
DOI: 10.1007/s12015-016-9662-8
PMCID: PMC4919381

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.PMID 27283945Read ↗

Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical ApplicationSemantic proximity Read ↗

Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell LinesSemantic proximity Read ↗

Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical ApplicationsSemantic proximity Read ↗

Good Manufacturing Practice–compliant human induced pluripotent stem cells: from bench to putative clinical productsSemantic proximity Read ↗

GMP-compatible manufacturing of three iPS cell lines from human peripheral bloodSemantic proximity Read ↗

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical ApplicationsSemantic proximity Read ↗

The safety of human pluripotent stem cells in clinical treatmentSemantic proximity Read ↗

Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ LayersSemantic proximity Read ↗

Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road AheadSemantic proximity Read ↗

Korea National Stem Cell BankSemantic proximity Read ↗

Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical ApplicationsSemantic proximity Read ↗

A practical guide to induced pluripotent stem cell research using patient samplesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.